Allotment of Equity Shares
Neuland Laboratories Ltd has informed BSE that the Board of Directors had allotted 1,000 fully paid up equity shares of a face value of Rs.10 each on October 24, 2016, to eligible employees pursuant to exercise of stock options granted under Employee Stock Option Scheme, 2008.Consequently w.e.f. October 24, 2016, the paid-up equity capital of the Company stands increased to Rs. 8,88,42,540/- from Rs. 8,88,32,540/-. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Neuland Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Limited Review Report for June 30, 2016
Neuland Laboratories Ltd has informed BSE about : 1. Standalone Limited Review for the period ended June 30, 2016 Shareholding for the Period Ended September 30, 2016
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Board Meeting Intimation for Results & Closure of Trading Window
Neuland Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company will be held on November 04, 2016, inter alia, to consider and take on record the Unaudited financial results of the Company for the quarter ended September 30, 2016.Further, as per the provisions of the Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for transactions in shares of the Company is closed from October...
InvAscent in talks to exit Neuland Group
InvAscent, which holds 33% stake in Neuland Group, has hired the investment banking arm of IDFC Bank to advise on the stake sale Statement on Impact of Audit Qualifications for the period ended March 31, 2015
Neuland Laboratories Ltd has submitted to BSE a copy of Standalone Statement on Impact of Audit Qualifications for the period ended March 31, 2015. Clarification
Neuland Laboratories Ltd has informed BSE regarding Clarification on in-principle approval for Merger of Neuland Health Sciences Private Limited (Holding Company) and Neuland Pharma Research Private Limited (subsidiary of the Holding Company) with Neuland Laboratories Limited. Neuland Labs gets board nod to merge 2 group cos with self
The merger is subject to all necessary approvals Outcome of Board Meeting
Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2016, have in-principle approved a proposal to merge Neuland Health Sciences Private Limited (Holding Company) and Neuland Pharma Research Private Limited (subsidiary of the Holding Company) with Neuland Laboratories Limited (theCompany"), subject to all necessary approvals.